ONS-1050 (trastuzumab biosimilar) / Zhejiang Huahai Pharma, Viropro, Syneos Health, Outlook Therap - LARVOL DELTA

Porosity Analysis of Additive Manufactured Parts Using CAQ Technology. (PubMed, Materials (Basel)) - "The radiation parameters used for getting 3D scans were voltage 180 kV, current 900 µA, detector resolution 1024 × 1024 px, voxel size 119.43 µm, number of projections 1050, and integration time 2000 ms...The porosity of the parts with Z and XZ orientation was also evaluated for parts' thicknesses of 1, 2, and 3 mm, respectively. It has been proven by this experimental investigation that the printing direction of the part in the additive manufacturing process under question affects its porosity."

Journal

ONS-1050: Initiation of P1 study in 2018 (Oncobiologics) - Pipeline Update

New P1 trial • Biosimilar